Chair of the Audit and Finance Committee
Viviane joined Ferring’s Board of Directors in July 2023 as Chair of the Audit and Finance Committee, having previously held senior positions at leading corporations in the life sciences and consumer sectors. She serves on the boards of BioMerieux, Pharvaris, ADC Therapeutics and Novo Holdings. She has also held Board roles at UCB, EUROAPI, DBV Technologies, Voluntis and Idorsia. Viviane was a Chief Financial Officer at Wyeth Pharmaceuticals/Pfizer, Novartis and Galderma, before becoming Vice-President Business Excellence Finance & Control at Nestlé. She holds a Bachelor’s degree and M.B.A. from the ESCP Business School, and an International Director Certificate from INSEAD, both in Paris, France. Viviane helps drive Ferring’s financial and sustainability performance and participates in the Board member forum of the Biopharma Sustainability Roundtable.
